June 08, 2021
The Third Circuit revived a pharmaceutical laboratory's trade secrets lawsuit against a former executive and Aurobindo Pharma units on Tuesday, ruling that a district court applied an improperly heavy burden on the lab to establish the proprietary information at issue and show how it was misused.